People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sexton Biotechnologies, Inc. | — | Biotechnology | Series A | $5.0M | $180.8M | 2019 |
| Mercury Bio, Inc. | — | Biotechnology | Seed | $3.9M | $5.8M | 2024 |
Mike Rice at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mike Rice on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eli Casdin | 1 | 6 |
| John Tomes | 1 | 4 |
| Alex Koglin | 1 | 2 |
| Dana Barnard | 1 | 1 |
| Bruce McCormick | 1 | 1 |
| Kevin McDonald | 1 | 1 |
| Tuck Stibich | 1 | 1 |
| Steve Buelow | 1 | 1 |
| Doug Dayhoff | 1 | 1 |
| Sean Werner | 1 | 1 |
| Brad King | 1 | 1 |
| Paul Laur | 1 | 1 |
| Steve Kiziuk | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.